| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10930472 | Cytotherapy | 2015 | 13 Pages |
Abstract
To a certain extent, BM-MNC or PB-MNC therapy for T2D demonstrated superiority of glycemic control, increased insulin biosynthesis and elevated insulin secretion from existing β-cells and might prevent islet cell loss.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Zheng-Xu Wang, Jun-Xia Cao, Duo Li, Xiao-Yan Zhang, Jin-Long Liu, Jun-Li Li, Min Wang, Yishan Liu, Bei-Lei Xu, Hai-Bo Wang,